Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Cardiovascular >> Blood >> Serum Proteins
Anti-Vitronectin antibody [VIT-2]
See all Vitronectin products (12) ...
Mouse monoclonal [VIT-2] to Vitronectin
Monoclonal Anti-Vitronectin recognizes both the 75 kDa and 65 kDa bands of human purified and plasma vitronectin in an immunoblotting assay. It does not crossreact with other extracellular matrix components such as fibronectin, laminin, merosin, collagen IV or chondroitin sulfate A, B and C in dot blot assays.
IHC-P, ELISA, WB, Dot Blot, ICCmore details
Reacts with
Human
Full length native protein (purified) (Human).
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 15mM Sodium Azide
Constituents: Ascites
Concentration information loading...
Ascites
Monoclonal
VIT-2
IgM
Immunology >> Innate Immunity >> Complement >> Regulatory
Cardiovascular >> Blood >> Serum Proteins
Western blot - Vitronectin antibody [VIT-2] (ab11591)
(enlarge)
Our Abpromise guarantee covers the use of ab11591 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
IHC-P: Use at an assay dependent dilution. (PubMed: 20675398)
ELISA: Use at an assay dependent dilution.
WB: 1/500Detects a band of approximately 75 , 65 kDa.(See Abreview (non-reduced samples).)
Dot: Use at an assay dependent dilution.
ICC: Use at an assay dependent dilution.
Vitronectin is a cell adhesion and spreading factor found in serum and tissues. Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.
Somatomedin-B is a growth hormone-dependent serum factor with protease-inhibiting activity.
Plasma.
Contains 4 hemopexin-like domains.
Contains 1 SMB (somatomedin-B) domain.
The SMB domain mediates interaction with SERPINE1/PAI1. The heparin-binding domain mediates interaction with insulin.
Sulfated on 2 tyrosine residues.
N- and O-glycosylated.
Phosphorylation on Thr-69 and Thr-76 favors cell adhesion and spreading.
It has been suggested that the active SMB domain may be permitted considerable disulfide bond heterogeneity or variability, thus two alternate disulfide patterns based on 3D structures are described with 1 disulfide bond conserved in both.
Phosphorylation sites are present in the extracelllular medium.
Secreted > extracellular space.
Target information above from: UniProt accessionP04004
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - Vitronectin antibody [VIT-2] (ab11591)
![Western blot - Vitronectin antibody [VIT-2] (ab11591)](/ps/datasheet/Images/11/ab11591/ab11591_1a.jpg)
All lanes : Anti-Vitronectin antibody [VIT-2] (ab11591) at 1/1500 dilution
Lane 1 : 25ul Human csf 3 days post injury
Lane 2 : 25ul Human csf 4 days post injury
Lane 3 : 25ul Human csf 5 days post injury
Lane 4 : 25ul Human csf 6 days post injury
Lane 5 : 0.365ug recombinant vitronectin
Secondary
HRP conjugated sheep anti-mouse IgG
developed using the ECL technique
Performed under non-reducing conditions.
Observed band size : 65,75 kDa (why is the actual band size different from the predicted?)
Exposure time : 2 minutes
This image is courtesy of an Abreview submitted by Dr Anki Nordqvist
This product has been referenced in:
See all 5 publications for this product
Publishing research using ab11591? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Western blot - Vitronectin antibody [VIT-2] (ab11591)](/ps/datasheet/Images/11/ab11591/ab11591_1a.jpg)
All lanes : Anti-Vitronectin antibody [VIT-2] (ab11591) at 1/1500 dilution
Lane 1 : 25ul Human csf 3 days post injury
Lane 2 : 25ul Human csf 4 days post injury
Lane 3 : 25ul Human csf 5 days post injury
Lane 4 : 25ul Human csf 6 days post injury
Lane 5 : 0.365ug recombinant vitronectin
Secondary
HRP conjugated sheep anti-mouse IgG
developed using the ECL technique
Performed under non-reducing conditions.
Observed band size : 65,75 kDa (why is the actual band size different from the predicted?)
Exposure time : 2 minutes
This image is courtesy of an Abreview submitted by Dr Anki Nordqvist
1
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
